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Abstract
Snail transcription factor is up-regulated in several cancers and associated with increased tumor migration and invasion via
induction of epithelial-to-mesenchymal transition (EMT). MAPK (ERK1/2) signaling regulates cellular processes including cell
motility, adhesion, and invasion. We investigated the regulation of ERK1/2 by Snail in breast cancer cells. ERK1/2 activity (p-
ERK) was higher in breast cancer patient tissue as compared to normal tissue. Snail and p-ERK were increased in several
breast cancer cell lines as compared to normal mammary epithelial cells. Snail knockdown in MDA-MB-231 and T47-D breast
cancer cells decreased or re-localized p-ERK from the nuclear compartment to the cytoplasm. Snail overexpression in MCF-7
breast cancer cells induced EMT, increased cell migration, decreased cell adhesion and also increased tumorigenicity. Snail
induced nuclear translocation of p-ERK, and the activation of its subcellular downstream effector, Elk-1. Inhibiting MAPK
activity with UO126 or knockdown of ERK2 isoform with siRNA in MCF-7 Snail cells reverted EMT induced by Snail as shown
by decreased Snail and vimentin expression, decreased cell migration and increased cell adhesion. Overall, our data suggest
that ERK2 isoform activation by Snail in aggressive breast cancer cells leads to EMT associated with increased cell migration
and decreased cell adhesion. This regulation is enhanced by positive feedback regulation of Snail by ERK2. Therefore,
therapeutic targeting of ERK2 isoform may be beneficial for breast cancer.
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Introduction
Breast cancer is the second most commonly diagnosed cancer,
accounting for almost 1 in 3 cancers diagnosed in US women [1].
One of the main causes of mortality from cancer is metastasis [2].
Epithelial-Mesenchymal Transition (EMT) is a process that
promotes tumor progression; Snail (snail1) transcription factor is
a C2H2 zinc finger protein that promotes EMT, which is
characterized by decreased expression of cell adhesion molecules
such as E-cadherin, VE-cadherin, Claudins, Occludin, Desmo-
plakin, Cytokeratins, and Mucin-1, and increased expression of
mesenchymal markers such as vimentin and N-cadherin [3,4].
Snail can be induced by growth factors such as transforming
growth factor beta (TGF-b) and epidermal growth factor (EGF)
[3]. Snail has been shown to increase resistance to apoptosis in
hepatocytes and Madine Darby Canine Kidney (MDCK) cells
[3,5–7]. Snail is induced by TGF-b and that upregulates pro-
inflammatory interleukins and matrix metalloproteinases (MMPs),
which help to degrade the extracellular matrix (ECM) [3]. This
activity shifts the microenvironment to a more radical and invasive
profile [6].
Modulation of Snail phosphorylation has been a hallmark of
several studies on Snail-mediated EMT [8–10]. Active Snail is
localized within the nucleus as a 264 amino acid transcriptional
repressor of target promoters, and is phosphorylated by a p21-
activated kinase 1 (PAK1) on Ser246 [11]. PAK1 phosphorylation
of Snail activates Snail protein and promotes Snail accumulation
within the nucleus to promote EMT. Snail is phosphorylated by
glycogen synthase kinase-3b (GSK-3b) at two consensus motifs
[12,13]. GSK-3b phosphorylation induces b-TRCP-mediated
ubiquitination, localization of Snail within the cytoplasm and
subsequent proteasomal degradation of Snail [13]. Additionally,
Snail phosphorylation by protein kinase D1 (PKD1) on Ser11
leads to nuclear export of Snail and EMT inhibition [14]. The zinc
finger domain of Snail serves as its nuclear localization sequence
and directs its movement into the nucleus [15]. Obtaining a better
understanding of the signaling pathways involved in breast cancer
will aid in developing more effective therapies and prevention
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strategies. Cross-communication between different pathways
allows cells to identify and respond appropriately to the
extracellular environment [16]. The receptor tyrosine kinases
(RTK) like epidermal growth factor receptor (EGFR), Ras/Raf/
MEK/ERK, and PI3K/AKT pathways are all involved in cancer
development, progression, and metastasis. Snail has been strongly
implicated in the Mitogen-activated protein kinase (MAPK)
pathway in breast cancer cells [17].
MAPK and extracellular-regulated kinases 1 and 2 (ERK1/2)
are significant signaling proteins that control several processes,
including: proliferation, survival, motility, adhesion, invasion and
survival [18]. The ERK1/2 cascade has several distinct functions
that differ depending on its subcellular localization. Nuclear
ERK1/2 activity (p-ERK) has been associated with malignant
mammary tumors and poor prognosis [19,20]. One study showed
that chemokine (C-X-C) ligand 5 (CXCL5) could activate Raf/
MEK/ERK, MSK1, Elk-1, and Snail, while E-cadherin was
down-regulated in breast cancer cell lines [17].
MAPK pathway inhibition has proven to be a promising
method of decreasing tumor growth by directly hindering cell
survival [18]. However, the use of oral MEK inhibitor CI-1040
(800 mg) to treat non-small-cell lung, breast, colon, and pancreatic
cancer has not been entirely successful [21]. Investigators reported
a dramatic increase in PI3K/Akt activity after administration of
CI-1040, indicating a shift in this pathway and potential tumor
resistance. Further studies deem hopeful, especially with a second
generation MEK inhibitor, PD 0325901 [21]. More importantly,
MAPK pathway inhibition has focused on general MAPK
inhibition without dissecting out the role of the different ERK
isoforms.
We investigated the role of Snail in regulating MAPK in breast
cancer cells and found that Snail and ERK1/2 activity was higher
in breast cancer cells as compared to normal mammary epithelial
cells. We have novel data that Snail overexpression in MCF-7
promotes nuclear ERK1/2 activation, resulting in Elk-1 activation
and EMT; Snail could be further regulated by ERK2 isoform by a
positive feedback mechanism. These findings begin to uncover
nuclear ERK2 isoform activity as a specific subcellular target of
therapy for aggressive breast cancer.
Materials and Methods
Cell Culture, Antibodies, and Reagents
The human breast cancer cells lines, T47-D, MCF-7, and
MDA-MB-231 were obtained from ATCC, Manassas, VA. The
MCF-7 cells stably transfected with empty Neo vector (MCF-7
Neo) and or constitutively active Snail (MCF-7 Snail) used for
most of these studies were kindly provided by Dr. Mien-Chie
Hung, The University of Texas MD Anderson Cancer Center,
Houston TX, and established as described previously [14]. Cells
were grown in RPMI medium supplemented with 10% fetal
bovine serum and 1% penicillin/streptomycin, at 37uC with 5%
CO2 in a humidified incubator. RPMI medium and penicillin/
streptomycin (P/S) were purchased from VWR Int., West Chester,
PA. Fetal bovine serum (FBS) and Charcoal/dextran treated FBS
(DCC-FBS) were from Hyclone, South Logan, UT. Matched
human tumor/normal breast cancer tissue lysates were purchased
from (Protein biotechnologies, Ramona, CA). Anti-human b-actin
antibody was from Sigma-Aldrich, Inc., St Louis, MO. Rat
monoclonal anti-Snail antibody, HRP-conjugated goat anti-rat
antibody, rabbit monoclonal anti-phospho-ERK antibody, rabbit
polyclonal anti-ERK antibody, rabbit polyclonal anti-phospho-
p90RSK (Thr359/Ser363), rabbit polyclonal anti-phospho-Elk-1
(Ser383), and rabbit monoclonal GAPDH (D16H11) antibodies
were from Cell Signaling Technology, Inc., Danvers, MA. Mouse
monoclonal E-cadherin, rabbit polyclonal p90RSK-1 (C-21), and
rabbit polyclonal Elk-1 (I-20), mouse monoclonal vimentin (V9),
and rabbit polyclonal topoisomerase I (H-300) antibodies were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
HRP-conjugated sheep anti-mouse, sheep anti-rabbit and the
Enhanced chemiluminescence prime (ECL prime) detection
reagent were purchased from Amersham Biosciences, Buckin-
ghamshire, UK. Luminata Forte HRP chemiluminescence detec-
tion reagent was purchased from EMD Millipore (Billerica, MA).
The protease inhibitor cocktail was from Roche Molecular
Biochemicals, Indianapolis, IN. from BD Biosciences, San Jose,
CA. Rat tail collagen type I and human fibronectin were from BD
Biosciences (Bedford, MA). UO126 (MEK1/2 inhibitor) and
MG132 were purchased from EMD Calbiochem (Billerica, MA).
Ethics Statement for Use of Animals
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All of
the animal procedures were approved and performed in accor-
dance with the Emory University Institutional IACUC guidelines.
Animal Experiments
Four-week-old female athymic nu/nu mice (National Cancer
Institute) were implanted subcutaneously with 17b-estradiol-
sustained release pellets and subsequently injected subcutaneously
with 26106 cells per mouse of Neo or Snail-overexpressing MCF-7
cells mixed 1:1 volume with matrigel (BD Biosciences). There were
6 mice in each group. The mice were sacrificed after 2 weeks by
carbon dioxide overdose followed by cervical dislocation, the
tumors excised and tumor volume measured with a caliper (tumor
volume was calculated as 3.14/66 largest diameter 6 smallest
diameter squared). The tumors were used for histology studies and
immunohistochemistry.
Ethical Statement Related to the Use of Human Breast
Tumor Samples
Breast tumors, and matched normal tissues were obtained from
the following sources- a) Protein biotechnologies, Ramona, CA; b)
US Biomax, Inc. (Catalog #BR1002, Rockville, MD). Protein
Biotechnologies Inc. provides pharmaceutical, biotechnology,
government, and academic institutions with human clinical
specimen derivatives. Tissues are obtained through a global
network of participating medical centers that employ IRB
approved protocols and strict ethical guidelines to ensure patient
confidentiality and safety. Identical procedures are used to prepare
all patient samples. Specimens are flash frozen to 2120uC within
5 min of removal to minimize autolysis, oxidation, and protein
degradation. Tissue specimens are homogenized in modified
RIPA buffer (PBS, pH 7.4, 1 mM EDTA, and protease inhibitors)
to obtain the soluble proteins, and centrifuged to clarify.
Tissue Microarray Analysis by Dual Immunofluorescence
The breast cancer and normal tissue microarray slide was
deparaffinized with xylene, dehydrated with alcohol series from
100% ethanol to 50% ethanol, antigens were retrieved at 125uC
for 30 seconds, peroxidases were blocked using 0.03% hydrogen
peroxide, and blocked using either goat or rabbit sera. Primary
antibodies (Snail anti-rat and p-ERK anti-rabbit) were added to
the slide and incubated overnight at 4uC. After washing with 16
Tris Buffered Saline-Tween (TBS-T) and 16 phosphate buffered
saline (PBS), secondary antibodies anti-rabbit Oregon green 488
Snail Regulates ERK2
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(Invitrogen, Carlsbad, CA) and anti-goat Texas red (Vector
Laboratories, Burlingame, CA) were added and incubated for
30 minutes in darkness. The slide was washed with 16 TBS-T,
counterstained with DAPI to detect nuclei, washed briefly with
double deionized water, and mounted using Fluorogel mounting
medium (Electron Microscopy Sciences, Hatfield, PA). Fluores-
cence microscopy was performed using Zeiss (Axiovision Rel 4.8)
and Apotome software.
Immunohistochemistry
Paraffin-embedded tumor tissues were sliced into 5 mm thick
sections and mounted on glass. The slides were deparaffinized and
rehydrated through a graded series of ethanols to deionized water
followed by antigen retrieval with Reveal Decloaker RTU antigen
unmasking solution (Biocare Medical, Concord, CA). The slides
were incubated with Snail primary antibody overnight at 4uC,
washed and incubated with HRP-conjugated secondary antibody
for 30 min at room temp. Slides were washed with TBS-T
365 min, 16PBS 365 min, then incubated with an avidin+biotin
solution from (Biocare Medical, Concord, CA). Slides were gently
and briefly washed with 16PBS two times; the first wash was for
5 min in a humidified chamber and the second wash was for
15 min with low agitation. Slides were incubated with 3,3-
Diaminobenzidine (DAB) for no more than 2 min at room temp.
Slides were washed with deionized water 365 min, dipped in
hematoxylin/eosin for 3 min, rinsed in tap water for 5 min, and
dehydrated in an up-graded series of ethanols. Slides were dipped
in xylene and mounted using a xylene-based mounting media.
Images of slides were taken using Zeiss microscope and Rel 4.8
software.
Immunofluorescence Using Breast Cancer Cell Lines
56103 cells were plated into 16 well chamber slides (Bio-Tek,
Nunc, Winooski, VT). For treatments, cells were either untreated,
treated with control siRNA or Snail siRNA. Fixation was
performed with methanol/ethanol 1:1 volume for 5 min, followed
by washes with 16 PBS and blocking with protein blocking
solution without serum (Dako, Camarillo, CA) for 10 min at room
temp. Subsequently, slides were incubated with primary antibody
at 1:50 or 1:100 dilutions in Dako antibody diluent solution for 1 h
at room temp. Slides were washed with 16 TBS-T (Dako,
Camarillo, CA), then incubated with secondary antibody in the
dark for 1 h at room temp. Secondary antibodies used were anti-
rabbit Oregon green 488, anti-mouse Alexa red 594 (Invitrogen,
Carlsbad, CA) or anti-goat Texas red (Vector Laboratories,
Burlingame, CA). Slides were washed with 16TBS-T and double
deionized water, prior to counterstaining with DAPI (1 mg/ml,
Santa Cruz Biotechnology, Santa Cruz, CA). Slides were mounted
using Fluorogel mounting medium (Electron Microscopy Sciences,
Hatfield, PA). Fluorescence microscopy was performed using Zeiss
microscope and Axiovision Rel 4.8 software.
Short Interfering RNA Transfection (siRNA)
Transient transfections were performed with 100 nM of non-
silencing ON-TARGET (Catalog #D-001810-10) or ON-TAR-
GETplus siRNA (Thermo Scientific - Dharmacon, Lafayette, CO)
for Snail, ERK 1 isoform and ERK 2 isoform, as per the
manufacturer’s instructions. Briefly, T47-D, MDA-MB-231,
MCF-7 Neo, and MCF-7 Snail cells were seeded overnight in 6-
well dishes then incubated with either non-silencing or siRNA
against Snail, ERK1 or ERK2 in phenol-free RPMI without FBS
or antibiotics for 5 hours; subsequently the media were replaced
with 5% DCC phenol-free RPMI for an additional 72 hours.
Lysates from whole cell, nuclear and cytoplasmic extracts were
harvested and quantitated for respective experiments.
Stable Snail Transfection in MCF-7
In order to confirm our findings from MCF-7 Neo and MCF-7
Snail cells obtained from Dr Mien-Chie Hung, we generated our
own stable cell lines as follows: Parental MCF-7 cells grown to
90% confluence in a 6 well culture dish were transfected with
either 1 mg of Snail cDNA or the empty neomycin vector (Neo),
using Lipofectamine 2000 according to manufacturer instructions.
(Invitrogen, San Diego, CA). Stable transfectants were selected by
treatment with 800 mg/ml of G418 and maintained in 400 mg/ml
G418. Selected clones were tested for Snail expression by Western
blot analysis.
Western Blot Analysis
Cells were lysed in a modified RIPA buffer (50 mM Tris
pH 8.0, 150 mM NaCl, 0.02% NaN3, 0.1% SDS, 1% NP-40,
0.5% sodium deoxycholate) containing 1.56 protease inhibitor
cocktail, 1 mM phenylmethylsufonyl fluoride (PMSF), and 1 mM
sodium orthovanadate. Whole cell lysates were freeze-thawed at 2
80uC/4uC for three cycles, then centrifuged at 13,500 rpm for
30 min at 4uC. Supernatants were collected and quantified using a
micro BCA assay (Promega, Madison, WI). 30–50 mg of cell
lysates were resolved using 10% SDS PAGE, followed by
transblotting onto nitrocellulose membrane (Bio-Rad Laborato-
ries, Hercules, CA). Membranes were blocked in 5% milk (TBS
with 0.05% Tween-20, 0.05% BSA containing 5% milk) or 3%
milk (TBS-T containing 3% milk), then washed and incubated
with primary antibody dilution buffer. After washing, the
membranes were incubated in peroxidase-conjugated sheep anti-
mouse, sheep anti-rabbit, or goat anti-rat IgG, washed, and
visualized using ECL prime reagent (GE Healthcare, Buckin-
ghamshire, UK) or Luminata Forte ECL reagent (Millipore,
Billerica, MA). The membranes were stripped using Restore
Western blot stripping buffer (Pierce Biotechnology, Inc., Rock-
ford, IL) prior to re-probing with a different antibody.
In vitro Cell Migration Assay
We utilized Costar 24-well plates containing a polycarbonate
filter insert with an 8- mm pore size, to coat with 3.67 mg/ ml rat
tail collagen I or 2.5 mg/cm2 human fibronectin on the outside for
24 h at 4uC. 56104 cells were plated in the upper chamber
containing RPMI supplemented with 0.1% fetal bovine serum
(FBS), whereas the lower chamber contained RPMI supplemented
with 10% FBS. After 5 h, cells that migrated to the bottom of the
insert were fixed, stained with 0.05% crystal violet, and counted to
obtain the relative migration.
In vitro Cell Adhesion Assay
96 well plates were coated with 3.67 mg/ ml of rat-tail collagen I
or 2.5 mg/cm2 of fibronectin overnight at 4uC. Binding sites were
blocked with 0.1% bovine serum albumin (BSA) in PBS followed
by plating of 36104 cells in complete RPMI. After incubation for
20 min, cells were treated with Percoll flotation medium and
Percoll fixative for 15 min at room temp, washed with 16 PBS
and stained with 0.05% crystal violet. The following day, each well
was solubilized with Sorenson solution, and OD read at 590 nm
using a Gen5 automated plate reader to quantify relative cell
adhesion.
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Subcellular Fractionation
Subcellular fractionations were performed per the manufactur-
er’s instructions (Thermo Scientific). Briefly, cells at 80–90%
confluence were lysed in a series of buffers containing protease
inhibitors (25X) with CERI (100 ml), CERII (5.5 ml), or NER
(50 ml). Centrifugation steps were performed to obtain a non-
nuclear fraction and an intact nuclear pellet, followed by further
lysing to isolate the nuclear fraction. 50 mg of non-nuclear and
nuclear fractions were utilized for Western blot analysis. Mouse
anti-topoisomerase I and mouse anti-GAPDH antibodies were
used to ensure the integrity of nuclear and non-nuclear fractions,
respectively.
Statistical Analysis
Data were analyzed by a paired student’s t-test or ANOVA
using GraphPad Prism software. ImageJ software was used to
quantitate densitometry. P values less than 0.05 were considered
statistically significant.
Results
p-ERK Is Increased in Patient Breast Tumor Tissues
We analyzed the expression of p-ERK and total ERK in
normal/tumor matched patient lysates using Western blot
analysis. Most of the tumor lysates expressed higher levels of p-
ERK as compared to normal tissue (Figure 1A). We analyzed the
expression of p-ERK and Snail using a human tissue microarray
containing normal and tumor tissue cores from patients. We found
that p-ERK was predominantly cytoplasmic in normal epithelial
tissue, while Snail was low (Figure 1B, Figure S1). The higher
grade tumor samples expressed a higher level of Snail and more
nuclear expression of p-ERK within epithelial cells, which co-
localized with Snail, as well as high p-ERK within the stroma
(Figure 1B, Figure S1). This confirms previous studies that p-ERK
is increased in breast cancer, while suggesting that Snail may co-
localize with p-ERK in breast cancer.
Snail Expression Is Associated with Increased p-ERK in
Breast Cancer Cells
We examined the expression of Snail transcription factor in a
panel of normal breast epithelial and breast cancer cells lines of
increasing aggressiveness by Western blot analysis. The normal
breast epithelial cells (HMEPiC) and MCF-7 breast cancer cell line
did not express detectable levels of Snail, while Snail was
detectable in breast cancer cell lines T47-D and higher in
MDA-MB-231, which displayed the highest cell migratory
potential (Figure 2A, B). p-ERK was also increased in breast
cancer cell lines as compared to normal breast epithelial cells
(Figure 2A). This demonstrates that Snail expression positively
associates with p-ERK and cell migration. To determine the
effects of Snail knockdown on p-ERK in T47-D and MDA-MB-
231 breast cancer cells, we transiently transfected these cells with
control siRNA or Snail siRNA and analyzed the expression of
Snail, p-ERK, and EMT markers (E-cadherin and vimentin) by
Western blot and immunofluorescence analyses. Snail knockdown
decreased p-ERK significantly in MDA-MB-231 and T47-D cells
(Figure 2C, D and Figure S2). Interestingly, there was also a
marked re-localization of p-ERK from the nucleus to the
cytoplasm upon Snail knockdown in T47-D cells, as seen by
immunofluorescence (Figure 2D, Figure S2). Additionally, Snail
knockdown increased levels of E-cadherin in T47-D and decreased
levels of vimentin in MDA-MB-231 cells, suggesting a partial
reversion of EMT (Figure 2C). These data demonstrate that Snail
and p-ERK increase with breast cancer progression and that Snail
may regulate ERK activity in breast cancer cells.
Snail Increases EMT In Vitro and Tumorigenicity In Vivo
Since hormone-dependent MCF-7 cells expressed barely
detectable levels of Snail, we utilized MCF-7 cells that have been
transfected with either the Neo empty vector or constitutively
active Snail cDNA for in vitro and in vivo studies. The MCF-7
Neo/MCF-7 Snail cell model has been used as an EMT
progression model for breast cancer [14]. We confirmed that
MCF-7 Neo cells maintain a more epithelial and cuboidal
morphology, which was completely transformed to a more
mesenchymal and fibroblast-like morphology in MCF-7 Snail
cells (Figure 3A). We also confirmed by Western blot analysis that
this model represents an EMT model by analyzing the expression
of EMT markers; MCF-7 Snail cells demonstrated higher levels of
Snail and vimentin and lower levels of E-cadherin as compared to
MCF-7 Neo cells (Figure 3B). We also analyzed the effects of Snail
overexpression on cell adhesion and migration using rat tail
collagen I and human fibronectin matrices, and found that MCF-7
Snail cells displayed decreased cell adhesion and increased cell
migration on both matrices (Figure 3C, 3D). To determine the
effects of Snail overexpression in vivo, we injected MCF-7 Neo
and MCF-7 Snail cells subcutaneously into female nude mice.
Significantly larger tumor volumes were observed in MCF-7 Snail
tumor xenografts as compared to MCF-7 Neo xenografts after 2
weeks (Figure 3E). H&E staining was performed as well as
immunohistochemistry to demonstrate higher expression of Snail
in MCF-7 Snail tumor xenograft tissues as compared to MCF-7
Neo tumor xenografts (Figure S3). Therefore, Snail increases
EMT and tumorigenicity in MCF-7 breast cancer cells.
Snail Promotes Nuclear Translocation of p-ERK
Next, we examined p-ERK levels upon Snail overexpression.
For this, we retransfected parental MCF-7 cells stably with
constitutively active Snail cDNA or empty Neo vector and selected
various clones of Neo and Snail. Using representative clones, we
observed that MCF-7 Snail clones that expressed high levels of
Snail also expressed higher p-ERK as compared to MCF-7 Neo
clones (Figure 4A). Interestingly, Snail overexpression correlated
with predominantly nuclear localization of p-ERK as observed by
immunofluorescence, while p-ERK was predominantly cytoplas-
mic, surrounding the nucleus in MCF-7 Neo cells (Figure 4B,
Figure S4). We further confirmed that Snail could regulate p-ERK
by knocking down Snail in a representative MCF7-Snail clone;
this led to decreased p-ERK (Figure 4C). We further examined p-
ERK localization utilizing Western blot analysis of nuclear and
cytoplasmic fractions. We observed that Snail overexpression led
to p-ERK primarily within the nuclear fraction as compared to the
cytoplasmic fraction (Figure 4D). However, in MCF-7 Neo cells,
although there was p-ERK in both the nuclear and cytoplasmic
fractions, it was interesting to note that it was predominantly the p-
ERK1 isoform (Figure 4D). Furthermore, we noted that in MCF-
7 parental cells, p-ERK staining was similar to MCF-7 Neo cells
and co-localized with nuclear import protein nucleoporin98
(NUP98), a nuclear membrane marker, suggesting that the
predominant nuclear expression of p-ERK within these cells
may reside within the nuclear membrane (data not shown). To
determine whether Snail-mediated nuclear translocation of p-
ERK may be associated with downstream effectors of p-ERK, we
reviewed literature about MAPK and its effectors within the
subcellular compartments and found that p90 ribosomal s6 kinase
(p90RSK) is a cytoplasmic substrate of p-ERK, while Elk-1
transcription factor is a nuclear substrate of p-ERK [23]. P90RSK
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and Elk-1 are involved in tumor progression and biochemical
changes in chromatin structure, and indirectly increasing cell
proliferation through c-Fos activation, respectively [23]. We
analyzed the protein expression of phosphorylated (active) and
total forms of p90RSK and Elk-1 in MCF-7 Neo and MCF-7 Snail
cells. We found that the p-p90RSK was expressed predominantly
within the cytoplasmic fractions of both MCF-7 Neo and MCF-7
Snail cells; however, p-Elk-1 was highly expressed predominantly
in the nuclear compartment and at significantly higher levels in
MCF-7 Snail as compared to MCF-7 Neo cells (Figure 4D).
Further evidence that Snail may promote activation of ERK1/2,
which subsequently activates Elk-1 was supported by the fact that
Snail knockdown in MDA-MB-231 cells led to translocation of p-
Elk-1 from the nucleus into the cytosol (Figure S5).
Inhibition of ERK Activity with UO126 Decreases Snail
Expression and Partially Reverts EMT Independent of
Proteasomal Degradation
MAPK/ERK signaling is closely involved with cancer devel-
opment, progression and metastasis [18,23,27]. We sought to
determine if Snail-mediated EMT may be regulated via p-ERK in
our model of breast cancer. To accomplish this task, we inhibited
p-ERK using MEK inhibitor UO126 (20 mM) for 30 min, 2 h,
6 h, and 24 h. MCF-7 Neo and MCF-7 Snail cells treated with
UO126 led to p-ERK inhibition within 30 min up to 24 h
(Figure 5A). Interestingly, Snail expression was decreased in MCF-
7 Snail cells within 24 h after UO126 treatment (Figure 5A). Also
noted, was the dramatic changes in MCF-7 Snail cell morphology
after UO126 treatment; the cells became more epithelial and
clumped after 24 h and were still viable as shown by DAPI
staining (Figure 5B). EMT was antagonized as shown by
decreased vimentin and increased E-cadherin expression (Fig-
ure 5C), which was associated with significant decrease in cell
migration and increase in cell adhesion (Figure 5E). To determine
whether ERK inhibition was inducing proteasomal-mediated
degradation of Snail, we pre-treated MCF-7 Neo and MCF-7
Snail cells with MG132 proteosomal degradation inhibitor for 2 h
prior to treatment with UO126 for 6 or 24 h. We observed that
inhibition of Snail expression following UO126 treatment was not
restored by MG132 (Figure 5D), suggesting that UO126 does not
decrease Snail protein expression via the proteosomal pathway.
Conversely, we observed that UO126 treatment of MCF-7 Neo
cells altered morphology and led to spindle–shaped cells with
extensions (Figure 5B, arrows), which was accompanied by
decreased expression of E-cadherin (Figure 5C), as well as
decreased cell adhesion (Figure 5E). These data suggest that
although Snail can regulate p-ERK, there may also be a feedback
loop by which p-ERK can also positively regulate Snail expression.
Furthermore, it appears that p-ERK inhibition in MCF-7 Snail
Figure 1. p-ERK expression is increased in patient tumor tissues. (A) 10 mg of normal/tumor-matched infiltrating ductal carcinoma (IDC)
grades 1–3 and lymph node metastatic patient lysates were separated using SDS-PAGE electrophoresis, then immunoblotted onto nitrocellulose.
Expression of p-ERK and ERK was determined using Western blot analysis. b-actin was used as Western blot loading control. (B) Human breast cancer
tissue microarray was double-labeled with p-ERK (green) and Snail (red) antibodies using immunofluorescence analysis. DAPI was used to identify the
nuclei. Images were captured using Zeiss Axiovision Rel4.8 at 206 (left panel) and Apotome software at and 406 oil magnification (right panel).
Results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0104987.g001
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cells reverts EMT, while surprisingly, p-ERK inhibition in MCF-7
Neo cells antagonizes cell adhesion.
ERK2 Isoform Regulates Snail Expression and EMT
Since we had observed that MCF-7 Neo cells expressed a higher
level of p-ERK1 isoform in both the cytoplasm and nuclear
fraction, whereas MCF-7 Snail cells expressed a higher level of p-
ERK1 and ERK2 isoform within the nuclear fraction, we
dissected the roles of the different isoforms further. In MCF-7
Neo cells, we observed that neither ERK1 nor ERK2 siRNA
affected Snail or vimentin expression, though E-cadherin levels
appeared to increase with ERK1 knockdown (Figure 6A).
However, in MCF-7 Snail cells, both ERK1 and ERK2 siRNA
decreased Snail and vimentin levels, but ERK2 siRNA decreased
Snail and vimentin more significantly; however, E-cadherin was
not affected (Figure 6B). Functionally, ERK2 siRNA decreased
cell migration in both MCF-7 Neo and MCF-7 Snail cells more
significantly as compared to ERK1 siRNA (Figure 6C). Moreover,
Figure 2. Snail is correlated with increased p-ERK in breast cancer cells. (A) Normal immortalized breast epithelial cells (HMEPiC), the
adenocarcinoma cell lines MCF-7 and T47-D, and triple negative cell line MDA-MB-231 were utilized to analyze Snail, p-ERK and total ERK protein
levels by Western blot analysis. (B) MCF-7, T47-D, and MDA-MB-231 cell lines were utilized to perform a migration assay on collagen. Cells that had
migrated through the boyden chamber insert were fixed, stained, counted and graphed. Bars, SD, paired Student’s t-test. (C) T47-D and MDA-MB-231
cells were transiently transfected with control siRNA or Snail siRNA and expression levels of Snail, p-ERK, and ERK were determined with Western blot
analysis (top panel). Relative protein levels compared to actin were analyzed by Image J analysis using National Institute of Health (NIH) software and
plotted (bottom panel). Bars, SD. Statistical analysis was done using ANOVA and Tukey’s Multiple Comparison as Post Hoc (* p#0.05, ** p#0.01). (D)
Immunofluorescent analysis was also performed on T47-D and MDA-MB-231 cells transiently transfected with control siRNA or Snail siRNA. b-actin
was utilized as a loading control for Western blot analysis; DAPI was used to identify the nuclei in immunofluorescent analyses. Magnification 20X;
Inset 40X. Results represent experiments performed in triplicate at least twice independently.
doi:10.1371/journal.pone.0104987.g002
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ERK2 siRNA was also more effective than ERK1 siRNA at
increasing cell adhesion in MCF-7 Snail cells (Figure 6D). This
suggests that ERK2 may be the primary regulator of Snail-
mediated EMT when compared to ERK1.
Discussion
Our research focused on the physiological functions influenced
by Snail transcription factor to promote to breast cancer
progression. Snail regulates epithelial-mesenchymal transition
(EMT), which involves a loss of epithelial markers like E-cadherin
and an increase in mesenchymal markers like vimentin [2,3,5].
Snail transcriptionally represses genes by binding to the enhancer
sequence (E-box) of genes such as E-cadherin, Occludin, Claudins,
and Mucin-1 [2,3]. Moreover, Snail induces resistance to cell
death, noted in skin tumors induced in mice, biopsies of breast
carcinomas from patients, gastric cancer, and hepatocellular
carcinomas [6]. This communication studied the relationship
between Snail and phosphorylated ERK (p-ERK), in an effort to
discover novel pathways by which ERK1/2 may be altered during
breast cancer progression.
ERK1/2 is involved in several functions of breast cancer
progression; ERK1/2 can regulate cell proliferation, survival,
motility, and differentiation by indirectly shifting normal mam-
mary epithelial cells into a more mesenchymal, less adherent state
[22]. Previous studies have indicated an evident link between
Snail, other Snail gene members (i.e., Snail, Slug, Twist) and
Figure 3. Snail increases EMT in vitro and tumorigenicity in vivo. (A) Morphology images of MCF-7 Neo and MCF-7 Snail cells were captured
by brightfield microscopy (1006magnification). (B) Expression of EMT markers Snail, E-cadherin, and Vimentin was analyzed using Western blot. (C)
Adhesion and (D) migration assays performed on collagen I and fibronectin matrices were imaged at 106magnification (left panel), counted and
graphed (right panel). (E) MCF-7 Neo or MCF-7 Snail cells were injected subcutaneously into nude female mice (N = 6) and two weeks later, mice were
sacrificed and tumor volumes measured and graphed. b-actin was utilized as a loading control for Western blot analysis. Statistical Analysis was done
using paired Student’s t-test, Bars, SD (**p,0.01, ***p,0.001). Results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0104987.g003
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MAPK/ERK signaling [2,18,23]. Snail has been shown to up-
regulate p-ERK which subsequently increases cell survival in
Madine Darby Canine Kidney (MDCK) cells [6]. Maintenance of
Slug (Snail2) gene expression promotes tumor motility through the
ERK signaling pathway in breast cancer [24]. Snail overexpres-
sion in ARCaP prostate cancer cells increased ERK activity, which
was associated with increased cell migration and decreased cell
adhesion [23].The present study associates Snail expression and p-
ERK with breast cancer progression, as Snail protein and ERK
activity was increased in breast cancer patient tissue as well as
breast cancer cell lines (MCF-7, T47-D) and triple negative breast
cancer cells (MDA-MB-231). MDA-MB-231 breast cancer cells
are highly aggressive and migratory, as previously published [25]
as well as in our study.
The expression of p-ERK and Snail were higher and co-
localized in higher grade tumors. These findings correspond to a
recent communication that analyzed p-ERK expression in patient
tumors [26]. High levels of p-ERK were associated with poor
prognosis based on poor differentiation, larger tumor sizes, and
higher stages of breast cancer. Transient Snail knockdown using
siRNA decreased p-ERK levels markedly in MDA-MB-231 cells,
and led to re-localization of p-ERK from the nucleus to the
cytoplasm in T47-D cells. Interestingly, the decreased p-ERK
levels in MDA-MB-231 cells following Snail knockdown was
accompanied by a shift in localization of p-Elk-1, a downstream
substrate of nuclear p-ERK, from the nucleus to the cytoplasm.
This would suggest that Snail may regulate p-ERK, and more
specifically regulate its localization in cancer cells. Subcellular
localization of ERK1/2 and its ability to undergo nucleocytoplas-
mic translocalization within the cell has been the focus of several
investigations [27]. Although ERK1/2 is found abundantly
throughout the cell in many organelles and cell structures, entry
of this protein into the nucleus is highly selective; one study
showed that nuclear entry of MAPK does not occur in primary
ovarian and mammary epithelial cells due to lower import activity
for ERK1/2 as compared to cancer cells [28]. These findings
suggest that targeting nuclear MAPK may be an appropriate
method to diagnose and/or treat cancer.
High levels of Snail expression and nuclear expression of
ERK1/2 have been shown in separate studies to correlate with
Figure 4. Snail promotes nuclear ERK activation. (A) MCF-7 parental cells were stably transfected with constitutively active Snail cDNA utilizing
lipofectamine 2000, and stable clones selected using G418 and isolated. Expression of Snail, p-ERK and ERK in representative Neo and Snail clones
was analyzed by Western blot analysis (top panel) and quantified (bottom panel). (B) Expression and localization of p-ERK in MCF-7 Neo and MCF-7
Snail cells was analyzed using immunofluorescence. (C) MCF-7 Snail cells were transiently transfected with either control or Snail siRNA for 72 h and
cell lysates analyzed for expression of Snail, p-ERK and ERK by Western blot analysis (left panel) and results of Western blots were quantified and
graphed (right panel). (D) Nuclear and cytoplasmic extracts were isolated from MCF-7 Neo and MCF-7 Snail cells. The expression of Snail, p-ERK, ERK,
p-Elk-1, Elk-1, p-p90RSK, and p90RSK was analyzed by Western blot analysis. b-actin was utilized as a loading control for Western blot analysis; DAPI
was used in immunofluorescence to identify the nuclei. Magnification, 636 oil. Topoisomerase I (Topo I) was utilized as a nuclear marker while
GAPDH was utilized as a cytoplasmic marker. Relative protein levels compared to actin was analyzed by Image J analysis using National Institute of
Health (NIH) software and plotted. Values were expressed as mean 6 S.E.M. Statistical analysis was done using ANOVA and Tukey’s Multiple
Comparison as Post Hoc (** p#0.01). Results are representative of experiments performed in triplicate.
doi:10.1371/journal.pone.0104987.g004
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poor prognosis and cancer cell growth [2,29]. We utilized the
MCF-7 Neo/MCF-7 Snail cell model to more closely study the
relationship between Snail expression and p-ERK. We confirmed
that MCF-7 Neo/MCF-7 represented an EMT model; indeed, we
found that when Snail is overexpressed in less invasive MCF-7
cells, the morphology of these cells shifted from epithelial to
mesenchymal and fibroblastic. Snail overexpression also decreased
E-cadherin epithelial marker while vimentin mesenchymal marker
was increased, which was concomitant with decreased cell
adhesion and increased cell migration. Additionally, Snail
overexpression increased tumorigenicity in vivo. This study
reports evidence for the first time, that Snail oncogene can
negatively regulate adhesion to fibronectin and collagen in breast
cancer cells, while also regulating other properties of epithelial cells
Figure 5. Inhibition of p-ERK with UO126 decreases Snail and reverts EMT independent of proteasomal degradation. (A) Expression
of p-ERK, ERK and Snail was analyzed by Western blot analysis in MCF-7 Neo and MCF-7 Snail cells treated with DMSO control (Ctrl) or UO126 for
30 min, 2 h, 6 h, and 24 h. (B) MCF-7 Neo and MC-7 Snail cells were treated with either DMSO (control) or UO126 and stained with DAPI. Cell
morphology and integrity were analyzed by merging DAPI immunofluorescence imaging with brightfield microscopy. (C) Expression of E-cadherin
and vimentin in cells treated with DMSO Ctrl or UO126 was analyzed by Western blot analysis. (D) MCF-7 Snail were treated for 6 h and 24 h with
DMSO Ctrl, UO126 and UO126+MG132. Cell lysates were analyzed by Western blot analysis. (E) Migration and (F) adhesion assays was performed on
MCF-7 Neo and MCF-7 Snail cells treated with DMSO Ctrl or UO126. b-actin was utilized as a loading control for Western blot analysis; DAPI was used
to identify the nuclei in immunofluorescence analyses. Maginification 40X. Statistical Analysis was done using ANOVA and Tukey’s Multiple
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Figure 6. ERK2 isoform regulates Snail expression and EMT. (A) MCF-7 Neo and (B) MCF-7 Snail cells were transiently transfected with various
constructs (I, II, III, V) of ERK1 and ERK2 siRNA for 72 h. Expression of p-ERK, ERK, Snail, E-cadherin, and vimentin was analyzed using Western blot (left
panel). Relative protein levels compared to actin were analyzed by Image J analysis using National Institute of Health (NIH) software and plotted with
Control siRNA set at 100% (right panel). (C) Migration and (D) adhesion assays were performed utilizing MCF-7 Neo and MCF-7 Snail cells transiently
transfected with ERK1 I or ERK2 IV siRNA. b-actin was utilized as a loading control for Western blot analysis. Statistical Analysis was done using ANOVA
and Tukey’s Multiple Comparison as Post Hoc (*p#0.05, **p#0.01, ***p#0.001; #p#0.05, ##p#0.01). Values were normalized to untreated controls
and expressed as mean 6 S.E.M (N = 3). Results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0104987.g006
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that have been previously studied (i.e., E-cadherin reduction and
increased migration). Our previous studies have shown that
similarly in prostate cancer cells, Snail can decrease cell adhesion
and increase cell migration by regulating integrin signaling, and
down-regulating maspin tumor suppressor [23,30].
The ERK/MSK1/Elk-1/Snail signaling pathway has been
associated with breast cancer progression in vitro and in vivo;
exogenous chemokine (C-X-C motif) ligand 5 (CXCL5) mimicked
the effect of breast tumor-associated osteoblast (TAOBs) activities
to induce Raf/MEK/ERK mediated up-regulation of Snail in
MCF-7 and MDA-MB-231, which resulted in decreased E-
cadherin expression [18]. We utilized our MCF-7 Neo/MCF-7
Snail cell model to more closely dissect out MAPK regulation by
Snail. We found that Snail overexpression in MCF-7 breast cancer
cells led to increased p-ERK levels, whose localization was
predominantly within the nucleus. Moreover, the MCF-7 Snail
cells with nuclear p-ERK also displayed increased activity of its
downstream substrate, Elk-1. A previous study examined expres-
sion of p-ERK in a total of 886 breast cancer patients and found
that surprisingly, p-ERK correlated inversely with tumor size [31].
However, they did not dissect out the localization of these low
levels of p-ERK. It is possible that some tumors with low levels of
p-ERK may actually have it localized within the nucleus, which
may allow sufficient ERK activity that correlates with poor
prognosis. These findings suggest that there may be a shift in
MAPK localization as breast cancer cells become more metastatic.
Surprisingly, MCF-7 Neo cells did express some p-ERK, but it was
noted that it was mostly due to the ERK1 isoform, which was
localized in the cytoplasm and the nucleus. However, we observed
that the activity of nuclear Elk-1 was minimal in MCF-7 Neo cells,
suggesting that p-ERK within these cells do not signal in the
nucleus via Elk-1. Previously, it has been shown that up-regulation
of ERK2 isoform activity contributed to increased invasion in
MDA-MB-231 cells, which was also corroborated by 3D cell
migration assays [32]. It is plausible that Snail may be able to
activate preferentially the ERK2 isoform, which may lead to Elk-1
activation. However, we cannot totally rule out Snail activation of
ERK1 isoform, which was also higher in nuclear extracts as
compared to cytoplasmic extracts.
Interestingly, though we showed that Snail can regulate p-ERK,
MAPK inhibition utilizing UO126 in MCF-7 Snail cells led to
decreased expression of Snail, reversion of EMT as evidenced by
increased E-cadherin, decreased vimentin, decreased cell migra-
tion and increased cell adhesion. Normally, the molecular half-life
of Snail is only about 25 min, and is highly unstable [14]. The
molecular mechanism that drives tightly-controlled Snail activa-
tion can include GSK-3b-directed phosphorylation that can
include b-TrCP-directed ubiquitination and eventually proteaso-
mal degradation [12,14]. We investigated whether proteasomal
degradation was the basis behind decreased Snail protein upon
inhibition of MAPK activity, by pre-treatment with MG132
proteosomal degradation inhibitor. However, we found that
MG132 did not prevent the loss of Snail protein upon UO126
treatment, suggesting that MAPK inhibition does not target Snail
for proteosomal degradation. It has been reported that AP-1
activation can be induced by cellular stress brought on by UV-
irradiation [33]. This mode of AP-1 activation induces Snail
expression through the MAPK pathway in keratinocytes. There-
fore, we propose that AP-1 activation may be an alternative
pathway by which MAPK may regulate Snail and subsequently
EMT. Moreover, we propose that Snail may promote EMT in
breast cancer cells possibly through activation of p-ERK and
preferentially the ERK2 isoform and not the ERK1 isoform since
MCF-7 Neo cells have high levels of p-ERK1 that does not
activate Elk-1 activity. In fact, inhibition of MAPK activity in
MCF-7 Neo cells led to decreased E-cadherin expression and
decreased cell adhesion; this is opposite to the effects observed in
MCF-7 Snail cells.
We studied a possible mechanism of differential activation of the
ERK1 and ERK2 isoforms, and their downstream targets during
EMT. ERK1 or ERK2 siRNA were used to analyze the effects on
EMT in MCF-7 Neo and MCF-7 Snail cells. ERK2 siRNA more
markedly decreased Snail and vimentin expression in MCF-7
Snail cells, which correlated with decreased migration and
increased adhesion when compared to ERK1 siRNA; however,
E-cadherin expression was not restored. This differs from the effect
of UO126, which was able not only to decrease Snail and vimentin
expression, but to also restore E-cadherin expression. Additionally,
while UO126 in MCF-7 Neo cells seemed to decrease E-cadherin
and increase cell adhesion, neither ERK1 nor ERK2 siRNA was
able to significantly affect cell migration or cell adhesion in MCF-7
Neo cells. These differences may be explained either by the level of
knockdown (it was not complete with the siRNA but there was
complete inhibition of p-ERK with UO126) or possibly due to the
effect of UO126 on other proteins apart from ERK1/2.
Therefore, our data suggest that although Snail can regulate p-
ERK, there is also a feedback loop by which p-ERK, particularly
the ERK2 isoform can positively regulate Snail expression. This
would corroborate previous studies showing that increased ERK2
isoform activity contributed to increased invasion and migration in
MDA-MB-231 [32].
Although most studies usually study ERK1/2 activity without
dissecting out the role of each isoform, recent studies are
suggesting that they may have different functions. For example,
it has recently been shown that although ERK1 and ERK2 share
85% homology in amino acid sequence and are activated by the
same factors and have the same substrates. ERK2 genetic
knockdown is embryonic lethal, while ERK1 genetic knockdown
causes impaired thymocyte maturation and synaptic plasticity
[34,35]. Additionally, studies have shown that ERK1 ablation in
mouse embryo fibroblasts and NIH3T3 cells increases ERK2
dependent signaling and increases cell growth, whereas ERK2
knockdown decreases cell proliferation [36]. These differences in
function between ERK1 and ERK2 mirror what we observe in
our present study, where we find that ERK2 is more effective than
ERK1 in mediating EMT, cell migration and cell adhesion.
However, the discrepancies we observe between UO126 and
ERK1 knockdown in MCF-7 Neo cells show that there is still
more work that needs to be done to dissect out the role of ERK1.
Our cell model was better able to dissect out the role of ERK2 on
EMT in breast cancer.
Clinical trials have attempted to treat breast cancer with CI-
1040 (PD184352), an orally active, highly potent selective MEK1
and MEK2 inhibitor, but were unsuccessful [22]. Breast cancer
patients treated with epidermal growth factor receptor (EGFR)
inhibitor, Gefitinib, suffered relapses, which were due to MAPK
inhibition that paradoxically lead to PI3K/AKT activation [21].
Others have found that ERK2 also functions to promote therapy
resistance [29,37,38]. Current clinical trials are testing the use of
MEK and PI3K inhibitors in order to generate more effective
therapeutic strategies. Our studies attempt to demonstrate that it
may be possible to target breast cancer progression by targeting
the ERK2 isoform, which will abrogate Snail-mediated signaling.
Collectively, our findings indicate for the first time that Snail-
mediated induction of EMT, increased cell migration and
decreased cell adhesion, may be mediated by p-ERK, and more
specifically, p-ERK2 isoform (Figure 7). This study demonstrates
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the significance of therapeutic targeting of Snail via targeting of
the ERK2 isoform in future investigations on breast cancer.
Supporting Information
Figure S1 Single and merged images for breast cancer tissue
microarray double-labeled with p-ERK and Snail antibodies. (A)
Normal breast tissue adjacent to cancer, (B) infiltrating ductal
carcinoma grade 1, (C) infiltrating ductal carcinoma grade 2, (D)
infiltrating ductal carcinoma grade 3. DAPI was used to stain the
nuclei. Images were captured at 406 (oil) magnification.
(TIF)
Figure S2 Single and merged images from immunofluorescent
staining for T47-D and MDA-MB-231 transiently transfected with
Snail siRNA. T47-D and MDA-MB-231 transiently transfected
with either control siRNA or Snail siRNA were analyzed by
immunofluorescent staining for p-ERK, ERK and Snail. Snail (A,
D), p-ERK (B, E), and ERK (C, F) primary antibodies were used
to determine subcellular localization in samples. DAPI was used to
stain the nuclei. Images were captured at 206magnification.
(TIF)
Figure S3 Snail is expressed in mouse tumor xenografts
overexpressing Snail. MCF-7 Neo and MCF-7 Snail cells were
injected subcutaneously into female nude mice (N = 6) and 2 weeks
later, mice sacrificed and tumor xenografts excised. Sections from
the tumor xenografts were stained with (A) hematoxylin/eosin
(H&E) to examine histology of the tissues as well as (B) Snail
primary antibody by immunohistochemistry. Images were cap-
tured at 106 and 206magnifications.
(TIF)
Figure S4 Snail and p-ERK co-localize in the nucleus of MCF-7
Snail transfectants while p-ERK is cytoplasmic in MCF-7 Neo
cells. (A) Snail, (B), p-ERK (C) and ERK were analyzed by
immunofluorescence in MCF-7 Neo and MCF-7 Snail cells.
Images were captured at 206magnification. (D) Another view of
p-ERK in MCF-7 Neo cells is shown at 406magnification. The
cell membrane of one of the epithelial cells can be seen (white
arrows) while the p-ERK is mostly cytoplasmic closer to the
nucleus. DAPI was used to stain the nuclei.
(TIF)
Figure S5 Snail knockdown correlates with nucleo-cytoplasmic
translocalization of p-Elk-1. MDA-MB-231 breast cancer cells
were transfected with either control siRNA or Snail siRNA. Cells
were analyzed by immunofluorescence with either (A) p-Elk-1 or
(B) Elk-1 primary antibodies. DAPI was used to stain the nuclei.
Images were captured at 206magnification.
(TIF)
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9. Smith AP, Verrecchia A, Fagà G, Doni M, Perna D, et al (2009) A positive role
for myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal
transition. Oncogene 28(3): 422–30.
10. Martı́nez-Estrada OM, Cullerés A, Soriano FX, Peinado H, Bolós V, et al (2006)
The transcription factors slug and snail act as repressors of claudin-1 expression
in epithelial cells. Biochem J 394(Pt 2): 449–57.
Figure 7. Snail promotes EMT via ERK2. Cells with low Snail
maintain an epithelial morphology. During cancer progression, the
expression of Snail increases, which promotes the nuclear localization of
p-ERK2 isoform. This leads to EMT characterized by decreased E-
cadherin, increased vimentin, decreased cell adhesion and increased
cell migration. By a positive feedback loop, p-ERK can increase Snail




PLOS ONE | www.plosone.org 12 August 2014 | Volume 9 | Issue 8 | e104987
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35. Pagès G, Guérin S, Grall D, Bonino F, Smith A, et al (1999) Defective
thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science
286(5443): 1374–1377.
36. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, et al (2006)
ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell
signaling differentially. J Biol 5(5): 14.
37. Aceves-Luquero CI, Agarwal A, Callejas-Valera JL, Arias-González L, Esparı́s-
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